First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 1,698.30 ($21.85) and last traded at GBX 1,698.30 ($21.85), with a volume of 316 shares traded. The stock had previously closed at GBX 1,676.05 ($21.57).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Price Performance
The company’s 50-day moving average price is GBX 1,589.06 and its 200-day moving average price is GBX 1,528.03. The firm has a market cap of £5.02 billion and a price-to-earnings ratio of -1,543.91. The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Recommended Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- What is Insider Trading? What You Can Learn from Insider Trading
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- P/E Ratio Calculation: How to Assess Stocks
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
